Julie A. Vetalice, Author at ORTHOWORLD

Meditech Spine Gains FDA Clearance for Cure Opel-C Plating System

Meditech Spine gained FDA 510(k) clearance to market the CURE Opel-C Plate implant system, an add-on technology to its CURE anterior cervical plate system and Talos-C HA interbody systems.

Sep 18, 2018

NuVasive Launches MAGEC X in UK

ORTHOFLASH Spine

NuVasive commenced U.K. launch of MAGEC X, an extension of its MAGEC line to treat Early Onset Scoliosis.

Sep 18, 2018

Spine Wave Launches Paramount Anterior Cervical Cage

ORTHOFLASH Spine

Spine Wave commenced full launch of the titanium Paramount® Anterior Cervical Cage for interbody fusion.

Sep 18, 2018

Zavation Acquires Pan Medical U.S. Corp.

Competitive Landscape Mergers & Acquisitions

Zavation acquired PanMed, a manufacturer of minimally invasive products used in the kyphoplasty and interventional radiology markets.

Sep 18, 2018

Safe Orthopaedics Launches SteriSpine Kyphoplasty System

ORTHOFLASH Spine

Safe Orthopaedics commenced full launch of its SteriSpine kyphoplasty system, used for vertebral augmentation.

Sep 18, 2018

ConforMIS, Smith & Nephew Settle Patent Dispute

Company Updates Competitive Landscape

ConforMIS will receive US $10.5MM from Smith & Nephew to settle a 2016 patent infringement lawsuit.

Sep 17, 2018

SpineVision Gains FDA Clearance, CE Mark for HEXANIUM TLIF Cage

ORTHOFLASH Spine

SpineVision received FDA (510)k clearance and CE Mark approval for the 3D-printed HEXANIUM TLIF cage.

Sep 17, 2018

Zimmer Biomet Launches Mobi-C in Japan

ORTHOFLASH Spine

Zimmer Biomet has commenced launch of the Mobi-C® Cervical Disc in Japan.

Sep 17, 2018

MIACH Orthopaedics Secures $22.5 Million to Support ACL Implant

Investments The Numbers

MIACH Orthopaedics completed US $22.5MM in financing to support manufacturing and continue clinical trials for the Bridge-Enhanced® ACL Repair (BEAR®) implant, designed to stimulate healing of torn anterior cruciate ligaments.

Sep 17, 2018

Bone Therapeutics’ ALLOB Achieves Primary Endpoint in Delayed-Union Fracture Study

Orthobiologics ORTHOFLASH

Bone Therapeutics reported all patients met the primary endpoint in the U.S. Phase I/IIA study of ALLOB® allogeneic bone-cell therapy in the treatment of delayed-union fractures.

Sep 14, 2018

Get the ORTHOWORLD Newsletter!

Contact Us